Quarterly report pursuant to Section 13 or 15(d)

INTANGIBLE ASSETS (Tables)

v3.23.2
INTANGIBLE ASSETS (Tables)
 6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF IDENTIFIABLE INTANGIBLE ASSETS CARRYING VALUE

The net carrying value of the identifiable intangible assets from all acquisitions as of June 30, 2023 and December 31, 2022 are as follows:

    

          As of
June 30, 2023		     As of
December 31, 2022		  
    Life     Carrying     Carrying  
    (Years)     Amount     Amount  
                   
Asuragen acquisition:                      
Thyroid   9     $ 8,519     $ 8,519  
RedPath acquisition:                      
Pancreas test   7       16,141       16,141  
Barrett’s test   9       6,682       6,682  
                       
CLIA Lab   2.3       609       609  
                       
Total         $ 31,951     $ 31,951  
                       
Accumulated Amortization       (31,725 )     (31,090 )
                       
Net Carrying Value         $ 226     $ 861